Transplant Diagnostics Market

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025

Report Code: MD 4870 Feb, 2020, by marketsandmarkets.com

[227 Pages Report] The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

Transplant Diagnostics Market, by Region,2023(USD billion)

The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019

The market, by technology, is segmented into molecular and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the market. The large share of this segment can be attributed to the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis.

The independence reference laboratories end-user segment accounted for the largest share of the transplant diagnostics market in 2019

Based on end user, the market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the market. The large share of this segment can be attributed to the rapid modernization and automation of diagnostic laboratories, growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories, and the growing number of organ transplantation procedures.

Transplant Diagnostics Market, by Region,2023(USD billion)

North America accounted for the largest share of the market in 2019

North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America.

Key Market Players

Some of the players in the transplant diagnostics market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), bioMιrieux SA (France), Immucor, Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Hologic, Inc. (US).

An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the market. Product launches were the most widely adopted growth strategies.

Bio-Rad Laboratories is the top player in the global market. The company offers various diagnostic imaging modalities and services for transplant diagnostic procedures in the market. To sustain its leadership position and ensure its future growth, the company has been focusing on product launches, agreements, and collaborations. The company also tries to evaluate new, emerging, and complementary technologies to identify new product opportunities.

Scope of the report

Report Metric

Details

Market size available for years

2017–2025

Base year considered

2018

Forecast period

2019–2025

Forecast units

Value (USD)

Segments covered

Product, technology, application, transplant type, end user, and region

Geographies covered

North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa

Companies covered

Major players covered include Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), bioMιrieux S.A., Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), GenDx (Netherlands), Biofortuna (UK), Takara Bio, and BAG Healthcare

This research report categorizes the transplant diagnostics market into the following segments and subsegments:

By Technology

  • Molecular Assay Technologies
    • PCR-Based Molecular Assays
      • Real-time PCR
      • Sequence-specific Primer-PCR
      • Sequence-specific Oligonucleotide-PCR
      • Other PCR-based Molecular Assays
    • Sequencing-based Molecular Assays
      • Sanger Sequencing
      • Next-generation Sequencing
      • Other Sequencing-based Molecular Assays
  • Non-molecular Assay Technologies

By Product & Service

  • Reagents & Consumables
  • Instruments
  • Software & Services

By Transplant Type

  • Solid Organ Transplantation
      • Kidney Transplantation
      • Liver Transplantation
      • Heart Transplantation
      • Lung Transplantation
      • Pancreas Transplantation
      • Other Organ Transplantations
  • Stem Cell Transplantation
  • Soft Tissue Transplantation
  • Bone marrow Transplantation

By Application

  • Diagnostic Applications
    • Pre-transplantation Diagnostics
      • Infectious Disease Testing
      • Histocompatibility Testing
      • Blood Profiling
    • Post-transplantation Diagnostics
  • Research Applications

By End User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • RoE
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East and Africa

Recent Developments (2016-2019):

  • In August 2019, Care Dx (US) acquired XynManagement (US) to simplify transplant quality tracking and waitlist management.
  • In March 2019, Hologic established a learning and experience center in Zaventem (Belgium) to create awareness among customers, healthcare professionals, and employees across Europe, the Middle East, and Africa about the benefits of diagnostic products, including transplant diagnostic products.
  • In February 2019, Care Dx (US) launched the Allosure for lung transplants.
  • In January 2018, F. Hoffman-LA Roche Limited (Switzerland) launched the Cobas Plasma Separation Card.

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of transplant diagnostic products across significant regions in the future?
  • Emerging countries show immense opportunities for the growth and adoption of transplant diagnostic instruments, related reagents & consumables, and software. Will this scenario continue in the next five years?
  • Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the newest trends and advancements in the transplant diagnostics market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 21)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Research
    2.2 Market Estimation Methodology
           2.2.1 Revenue Mapping-Based Market Estimation
           2.2.2 Procedure-Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 40)
    4.1 Transplant Diagnostics Market Overview
    4.2 Market, By Technology
    4.3 Regional Analysis: Market, By Application
    4.4 Asia Pacific: Market, By End User, 2019
    4.5 Regional Analysis: Market, By Product & Service
    4.6 Regional Analysis: Market, By Transplant Type
    4.7 Market, By Country

5 Market Overview (Page No. - 47)
    5.1 Introduction 
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Increasing Number of Transplant Procedures
                    5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics
                    5.2.1.3 Increasing Public-Private Funding for Target Research Activities
                    5.2.1.4 Increasing Prevalence of Infectious Diseases
           5.2.2 Key Market Restraints
                    5.2.2.1 High Procedural Cost of Ngs- and Pcr-Based Diagnostic Assays
                    5.2.2.2 Limited Reimbursements for Target Procedures
           5.2.3 Key Market Opportunities
                    5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
                    5.2.3.2 Growing Public Awareness About Organ Donation and Transplantation
           5.2.4 Key Market Challenges
                    5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
                    5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Technology (Page No. - 55)
    6.1 Introduction
    6.2 Molecular Assay Technologies
           6.2.1 Pcr-Based Molecular Assays
                    6.2.1.1 Sequence-Specific Oligonucleotide-Pcr
                               6.2.1.1.1 Sso-Pcr is the Most Widely Adopted Technique in the Pcr-Based Molecular Assays Market
                    6.2.1.2 Sequence-Specific Primer-Pcr
                               6.2.1.2.1 Growing Public-Private Investments for Research Activities to Support Market Growth
                    6.2.1.3 Real-Time Pcr
                               6.2.1.3.1 Real-Time Pcr Requires Smaller Sample Volumes As Compared to Conventional Pcr Technologies
                    6.2.1.4 Other Pcr-Based Molecular Assays
           6.2.2 Sequencing-Based Molecular Assays
                    6.2.2.1 Sanger Sequencing
                               6.2.2.1.1 Sanger Sequencing Segment to Register the Highest Growth in the Sequencing-Based Molecular Assays Market
                    6.2.2.2 Next-Generation Sequencing
                               6.2.2.2.1 Low Turnaround Time & High Throughput Sequencing are the Major Factors Supporting the Adoption of Ngs
                    6.2.2.3 Other Sequencing-Based Molecular Assays
    6.3 Non-Molecular Assay Technologies
           6.3.1 Replacement of Non-Molecular Assay Techniques With Dna-Based Techniques is Expected to Hamper Market Growth

7 Transplant Diagnostics Market, By Product & Service (Page No. - 73)
    7.1 Introduction
    7.2 Reagents & Consumables
           7.2.1 Reagents & Consumables—the Largest & Fastest-Growing Segment in the Market
    7.3 Instruments
           7.3.1 Increasing Public-Private Investments Will Support Market Growth
    7.4 Software & Services
           7.4.1 Growing Automation & Digitalization of Diagnostic Laboratory Procedures are Supporting Market Growth

8 Transplant Diagnostics Market, By Application (Page No. - 78)
    8.1 Introduction
    8.2 Diagnostic Applications
           8.2.1 Pre-Transplantation Diagnostics
                    8.2.1.1 Infectious Disease Testing
                               8.2.1.1.1 Growing Adoption of Advanced Molecular Techniques for Pathogen Detection to Drive Market Growth
                    8.2.1.2 Histocompatibility Testing
                               8.2.1.2.1 Technological Advancements and Growing R&D Activities Indicate Strong Growth Potential in This Segment
                    8.2.1.3 Blood Profiling
                               8.2.1.3.1 Growing Availability of Molecular Assay Products has Supported Market Growth
           8.2.2 Post-Transplantation Diagnostics
                    8.2.2.1 Greater Risk of Disorders & Infections Post-Transplantation Makes Diagnostics A Necessary Step
    8.3 Research Applications
           8.3.1 Growing Funding for Research has Driven Market Growth

9 Transplant Diagnostics Market, By Transplant Type (Page No. - 86)
    9.1 Introduction
    9.2 Solid Organ Transplantation
           9.2.1 Kidney Transplantation
                    9.2.1.1 Market Growth is Mainly Driven By Rising Kidney Disease Prevalence
           9.2.2 Liver Transplantation
                    9.2.2.1 Growing Patient Population With Chronic Liver Diseases and Increasing Procedural Volume are the Key Indicators of Market Growth
           9.2.3 Lung Transplantation
                    9.2.3.1 Rising Prevalence of Chronic Lung Disease is A Key Growth Driver of This Market Segment
           9.2.4 Heart Transplantation
                    9.2.4.1 Rising Procedural Volume Indicates Strong Growth Prospects
           9.2.5 Pancreas Transplantation
                    9.2.5.1 Procedural Complexity and the Risk of Surgical Complications Have Restrained the Demand for Market Products in This Segment
           9.2.6 Other Organ Transplantations
    9.3 Stem Cell Transplantation
           9.3.1 Rising Procedural Volume and Growing Research Activities are Driving the Growth of the Market
    9.4 Soft Tissue Transplantation
           9.4.1 Technological Advancements and Rising Prevalence of Target Diseases Have Driven Market Growth
    9.5 Bone Marrow Transplantation
           9.5.1 Dearth of Well-Trained Surgeons to Perform Bone Marrow Transplantation is Expected to Hinder Market Growth

10 Transplant Diagnostics Market, By End User (Page No. - 98)
     10.1 Introduction
     10.2 Independent Reference Laboratories
             10.2.1 Rising Consolidation of Diagnostic Laboratories to Drive Market Growth
     10.3 Hospitals & Transplant Centers
             10.3.1 Growing Purchasing Power of Hospitals & Transplant Centers has Resulted in High Market Growth
     10.4 Research Laboratories & Academic Institutes
             10.4.1 Growing Awareness About the Genetic Techniques in Transplant Rejection Monitoring to Drive Market Growth

11 Transplant Diagnostics Market, By Region (Page No. - 104)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 Ongoing Technological Advancements in the Field of Transplant Diagnostics to Drive Market Growth in the US
             11.2.2 Canada
                        11.2.2.1 Growing Availability of Transplant Diagnostic Products to Support Market Growth in Canada
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Germany Accounted for the Largest Share of the European Market
             11.3.2 UK
                        11.3.2.1 Rising Number of Transplantation Procedures to Drive Market Growth in the UK
             11.3.3 France
                        11.3.3.1 Adoption of Molecular Diagnostic Techniques for Donor-Recipient Compatibility Testing is Increasing in France
             11.3.4 Spain
                        11.3.4.1 Rising Number of Solid Organ Transplantation Procedures to Drive Market Growth in Spain
             11.3.5 Italy
                        11.3.5.1 Sluggish Growth in the Italian Healthcare Sector in the Last Few Years to Restrain Market Growth
             11.3.6 Rest of Europe
     11.4 Asia Pacific
             11.4.1 China
                        11.4.1.1 Healthcare Infrastructural Improvements to Support Market Growth in China
             11.4.2 India
                        11.4.2.1 Increasing Number of Transplantation Procedures to Drive Market Growth in India
             11.4.3 Japan
                        11.4.3.1 Significant Growth in Chronic Disease Prevalence to Support Market Growth in Japan
             11.4.4 Australia
                        11.4.4.1 Rising Number of Solid Organ Transplantation Procedures to Support Market Growth in Australia
             11.4.5 South Korea
                        11.4.5.1 Government Initiatives to Introduce Medical Coverage for Transplantation to Support Market Growth in South Korea
             11.4.6 Rest of Asia Pacific
     11.5 Latin America
             11.5.1 Brazil
                        11.5.1.1 Brazil Accounted for the Largest Share of the Latam Market
             11.5.2 Mexico
                        11.5.2.1 Rising Medical Tourism to Support Market Growth in Mexico
             11.5.3 Rest of Latam
     11.6 Middle East & Africa

12 Competitive Landscape (Page No. - 151)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Scenario
             12.3.1 Product Launches & Enhancements
             12.3.2 Agreements, Partnerships, and Collaborations
             12.3.3 Acquisitions
             12.3.4 Expansions
     12.4 Competitive Leadership Mapping
             12.4.1 Visionary Leaders
             12.4.2 Innovators
             12.4.3 Dynamic Differentiators
             12.4.4 Emerging Companies

13 Company Profiles (Page No. - 158)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     13.1 Becton, Dickinson and Company
     13.2 Biofortuna
     13.3 Biomιrieux SA
     13.4 Bio-Rad Laboratories
     13.5 Caredx
     13.6 F. Hoffman-La Roche Limited
     13.7 Gendx
     13.8 Hologic, Inc.
     13.9 Illumina, Inc.
     13.10 Immucor, Inc.
     13.11 Luminex Corporation
     13.12 Merck KGaA
     13.13 Omixon
     13.14 Qiagen Nv
     13.15 Thermo Fisher Scientific
     13.16 Emerging Players
             13.16.1 Alpha Biotech, Ltd.
             13.16.2 Bag Healthcare
             13.16.3 Hansa Biopharma AB
             13.16.4 Histogenetics LLC
             13.16.5 Pacific Biosciences of California, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. 

14 Appendix (Page No. - 209)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Available Customizations
     14.4 Related Reports
     14.5 Author Details


List of Tables (153 Tables)

Table 1 Public-Private Investments and Research Grants for the Development of Transplant Diagnostic Products, 2015–2018
Table 2 Cost of Assays for Major Ngs/Pcr-Based Genomic Tests in Europe (As of 2017)
Table 3 Medical Reimbursements for Transplantation Procedures in the US (2017)
Table 4 Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 5 Market for Molecular Assay Technologies, By Type, 2017–2025 (USD Million)
Table 6 Market for Molecular Assay Technologies, By Product, 2017–2025 (USD Million)
Table 7 Market for Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 8 Market for Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 9 Market for Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 10 Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 11 Market for Pcr-Based Molecular Assays, By Product, 2017–2025 (USD Million)
Table 12 Market for Pcr-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 13 Market for Pcr-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 14 Market for Pcr-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 15 Market for Sequence-Specific Oligonucleotide-Pcr, By Region, 2017–2025 (USD Million)
Table 16 Market for Sequence-Specific Primer-Pcr, By Region, 2017–2025 (USD Million)
Table 17 Market for Real-Time Pcr, By Region, 2017–2025 (USD Million)
Table 18 Market for Other Pcr-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 19 Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 20 Market for Sequencing-Based Molecular Assays, By Product, 2017–2025 (USD Million)
Table 21 Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 22 Market for Sequencing-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 23 Market for Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 24 Market for Sanger Sequencing, By Region, 2017–2025 (USD Million)
Table 25 Market for Next-Generation Sequencing, By Region, 2017–2025 (USD Million)
Table 26 Market for Other Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 27 Market for Non-Molecular Assay Technologies, By Product, 2017–2025 (USD Million)
Table 28 Market for Non-Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 29 Transplant Diagnostics Market for Non-Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 30 Market for Non-Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 31 Market, By Product & Service, 2017–2025 (USD Million)
Table 32 Market for Reagents & Consumables, By Region, 2017–2025 (USD Million)
Table 33 Market for Instruments, By Region, 2017–2025 (USD Million)
Table 34 Market for Software & Services, By Region, 2017–2025 (USD Million)
Table 35 Market, By Application, 2019–2025 (USD Million)
Table 36 Market for Diagnostic Applications, By Type, 2019–2025 (USD Million)
Table 37 Market for Diagnostic Applications, By Region, 2019–2025 (USD Million)
Table 38 Pre-Transplantation Diagnostics Market, By Type, 2019–2025 (USD Million)
Table 39 Pre-Transplantation Diagnostics Market, By Region, 2019–2025 (USD Million)
Table 40 Infectious Disease Testing Applications Market, By Region, 2019–2025 (USD Million)
Table 41 Histocompatibility Testing Applications Market, By Region, 2019–2025 (USD Million)
Table 42 Blood Profiling Applications Market, By Region, 2019–2025 (USD Million)
Table 43 Post-Transplantation Diagnostics Market, By Region, 2019–2025 (USD Million)
Table 44 Transplant Diagnostics Market for Research Applications, By Region, 2019–2025 (USD Million)
Table 45 Market, By Transplant Type, 2019–2025 (USD Million)
Table 46 Solid Organ Transplantation Market, By Type, 2019–2025 (USD Million)
Table 47 Solid Organ Transplantation Market, By Region, 2019–2025 (USD Million)
Table 48 Kidney Transplantation Market, By Region, 2016–2023 (USD Million)
Table 49 Liver Transplantation Market, By Region, 2016–2023 (USD Million)
Table 50 Lung Transplantation Market, By Region, 2019–2025 (USD Million)
Table 51 Heart Transplantation Market, By Region, 2019–2025 (USD Million)
Table 52 Pancreas Transplantation Market, By Region, 2019–2025 (USD Million)
Table 53 Other Organ Transplantations Market, By Region, 2019–2025 (USD Million)
Table 54 Stem Cell Transplantation Market, By Region, 2019–2025 (USD Million)
Table 55 Soft Tissue Transplantation Market, By Region, 2019–2025 (USD Million)
Table 56 Bone Marrow Transplantation Market, By Region, 2019–2025 (USD Million)
Table 57 Transplant Diagnostics Market, By End User, 2017–2025 (USD Million)
Table 58 Market for Independent Reference Laboratories, By Region, 2017–2025 (USD Million)
Table 59 Market for Hospitals & Transplant Centers, By Region, 2017–2025 (USD Million)
Table 60 Market for Research Laboratories & Academic Institutes, By Region, 2017–2025 (USD Million)
Table 61 Market, By Region, 2017–2025 (USD Million)
Table 62 North America: Transplant Diagnostics Market, By Country, 2017–2025 (USD Million)
Table 63 North America: Market, By Technology, 2017–2025 (USD Million)
Table 64 North America: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 65 North America: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 66 North America: Market, By Product & Service, 2017–2025 (USD Million)
Table 67 North America: Market, By Application, 2017–2025 (USD Million)
Table 68 North America: Market, By Transplant Type, 2017–2025 (USD Million)
Table 69 North America: Transplant Diagnostics Market, By End User, 2017–2025 (USD Million)
Table 70 US: Market, By Technology, 2017–2025 (USD Million)
Table 71 US: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 72 US: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 73 Canada: Market, By Technology, 2017–2025 (USD Million)
Table 74 Canada: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 75 Canada: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 76 Europe: Market, By Country, 2017–2025 (USD Million)
Table 77 Europe: Market, By Technology, 2017–2025 (USD Million)
Table 78 Europe: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 79 Europe: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 80 Europe: Market, By Product & Service, 2017–2025 (USD Million)
Table 81 Europe: Market, By Application, 2017–2025 (USD Million)
Table 82 Europe: Market, By Transplant Type, 2017–2025 (USD Million)
Table 83 Europe: Market, By End User, 2017–2025 (USD Million)
Table 84 Germany: Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 85 Germany: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 86 Germany: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 87 Number of Organ Transplantation Procedures Performed in the UK, 2015 Vs. 2018
Table 88 UK: Market, By Technology, 2017–2025 (USD Million)
Table 89 UK: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 90 UK: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 91 France: Market, By Technology, 2017–2025 (USD Million)
Table 92 France: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 93 France: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 94 Spain: Market, By Technology, 2017–2025 (USD Million)
Table 95 Spain: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 96 Spain: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 97 Italy: Market, By Technology, 2017–2025 (USD Million)
Table 98 Italy: Transplant Diagnostics Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 99 Italy: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 100 RoE: Market, By Technology, 2017–2025 (USD Million)
Table 101 RoE: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 102 RoE: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 103 Asia Pacific: Market, By Country, 2017–2025 (USD Million)
Table 104 Asia Pacific: Market, By Technology, 2017–2025 (USD Million)
Table 105 Asia Pacific: Transplant Diagnostics Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 106 Asia Pacific: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 107 Asia Pacific: Market, By Product & Service, 2017–2025 (USD Million)
Table 108 Asia Pacific: Market, By Application, 2017–2025 (USD Million)
Table 109 Asia Pacific: Market, By Transplant Type, 2017–2025 (USD Million)
Table 110 Asia Pacific: Market, By End User, 2017–2025 (USD Million)
Table 111 Number of Organ Transplantation Procedures Performed in China, 2015 Vs. 2018
Table 112 China: Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 113 China: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 114 China: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 115 India: Market, By Technology, 2017–2025 (USD Million)
Table 116 India: Transplant Diagnostics Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 117 India: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 118 Japan: Market, By Technology, 2017–2025 (USD Million)
Table 119 Japan: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 120 Japan: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 121 Australia: Market, By Technology, 2017–2025 (USD Million)
Table 122 Australia: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 123 Australia: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 124 South Korea: Market, By Technology, 2017–2025 (USD Million)
Table 125 South Korea: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 126 South Korea: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 127 RoAPAC: Market, By Technology, 2017–2025 (USD Million)
Table 128 RoAPAC: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 129 RoAPAC: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 130 Latam: Market, By Country, 2017–2025 (USD Million)
Table 131 Latam: Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 132 Latam: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 133 Latam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 134 Latam: Market, By Product & Service, 2017–2025 (USD Million)
Table 135 Latam: Market, By Application, 2017–2025 (USD Million)
Table 136 Latam: Market, By Transplant Type, 2017–2025 (USD Million)
Table 137 Latam: Market, By End User, 2017–2025 (USD Million)
Table 138 Brazil: Market, By Technology, 2017–2025 (USD Million)
Table 139 Brazil: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 140 Brazil: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 141 Mexico: Market, By Technology, 2017–2025 (USD Million)
Table 142 Mexico: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 143 Mexico: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 144 Rolatam: Market, By Technology, 2017–2025 (USD Million)
Table 145 Rolatam: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 146 Rolatam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 147 MEA: Market, By Technology, 2017–2025 (USD Million)
Table 148 MEA: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 149 MEA: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 150 MEA: Market, By Product & Service, 2017–2025 (USD Million)
Table 151 MEA: Market, By Application, 2017–2025 (USD Million)
Table 152 MEA: Transplant Diagnostics Market, By Transplant Type, 2017–2025 (USD Million)
Table 153 MEA: Market, By End User, 2017–2025 (USD Million)


List of Figures (45 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries: Global Transplant Diagnostics Market
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Market
Figure 5 Data Triangulation Methodology
Figure 6 Reagents & Consumables Will Continue to Dominate the Transplant Diagnostics Market in 2025
Figure 7 Sequence-Specific Oligonucleotide-Pcr Segment Will Dominate the Market in 2025
Figure 8 Kidney Transplantation Segment Accounted for the Largest Share of the Market in 2019
Figure 9 Infectious Disease Testing Segment Dominates the Transplant Diagnostics Market, By Application
Figure 10 Independent Reference Laboratories—the Fastest-Growing End-User Segment in the Market
Figure 11 Geographical Snapshot of the Market
Figure 12 Rising Number of Transplantation Procedures Will Drive the Demand for Transplant Diagnostic Products During the Forecast Period
Figure 13 Pcr-Based Molecular Assays to Dominate the Transplant Diagnostics Market During the Forecast Period
Figure 14 Infectious Disease Testing and Histocompatibility Testing Segments to Witness High Growth in the Asia Pacific Market
Figure 15 Independent Reference Laboratories Will Dominate the Asia Pacific Transplant Diagnostics End-User Market in 2019
Figure 16 North America Was the Largest Market for All Products & Services in 2019
Figure 17 Kidney Transplantation Segment to Dominate the Transplant Diagnostics Market During the Forecast Period
Figure 18 China is Estimated to Be the Fastest-Growing Market
Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Number of Kidney Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 21 Number of Liver Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 22 Number of Lung Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 23 Number of Heart Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 24 Number of Pancreas Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 25 North America: Transplant Diagnostics Market Snapshot
Figure 26 Solid Organ Transplantations Performed in the Us, 2015–2019
Figure 27 Solid Organ Transplantation Procedures Performed in Canada, 2015–2018
Figure 28 Europe: Market Snapshot
Figure 29 Asia Pacific: Market Snapshot
Figure 30 Number of Solid Organ Transplantation Procedures Performed in Japan, 2015–2018
Figure 31 Key Growth Strategies Adopted By Market Players From 2016 to 2019
Figure 32 Bio-Rad Laboratories Held the Leading Position in the Transplant Diagnostics Market
Figure 33 Market: Competitive Leadership Mapping, 2019
Figure 34 Becton, Dickinson and Company: Company Snapshot (2019)
Figure 35 Biomιrieux Sa: Company Snapshot (2018)
Figure 36 Bio-Rad Laboratories: Company Snapshot (2018)
Figure 37 Caredx: Company Snapshot (2018)
Figure 38 F. Hoffman-La Roche Limited: Company Snapshot (2018)
Figure 39 Hologic, Inc.: Company Snapshot (2019)
Figure 40 Illumina, Inc.: Company Snapshot (2018)
Figure 41 Immucor, Inc.: Company Snapshot (2016)
Figure 42 Luminex Corporation: Company Snapshot (2018)
Figure 43 Merck KGaA: Company Snapshot (2018)
Figure 44 Qiagen Nv: Company Snapshot (2018)
Figure 45 Thermo Fisher Scientific: Company Snapshot (2018)

The study involved four major activities in estimating the current size of the transplant diagnostics market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to identify and collect information for this study.

Primary Research

The transplant diagnostics market comprises several stakeholders such as original equipment manufacturers (OEMs), product distributors and channel partners, hospitals and transplant centers, emergency care units and trauma centers, diagnostic laboratories, contract manufacturers and third-party suppliers, research laboratories and academic institutes, clinical research organizations (CROs), government and non-governmental regulatory authorities, and market research and consulting firms. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Transplant Diagnostics Market, by Region,2023(USD billion)

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the value of the transplant diagnostics market and other dependent submarkets, as mentioned below.

  • Key players in the global market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology included the study of the annual and quarterly financial reports & regulatory filings of significant market players as well as interviews with industry experts for detailed market insights.
  • All percentage shares, splits, and breakdowns for the global market were determined using secondary sources and verified through primary sources.
  • All key macroindicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.
  • The gathered market data was consolidated and added to detailed inputs, analyzed, and presented in this report.

Data Triangulation

After arriving at the overall market size of the global transplant diagnostics market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both the demand- and supply-side participants.

Report Objectives

  • To define, describe, and forecast the market based on product, technology, application, transplant type, end user, and region
  • To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and their contributions to the overall transplant diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the market value of various segments and subsegments for five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the market and comprehensively analyze their global revenue shares and core competencies
  • To track and analyze competitive market-specific developments such as product launches/approvals and enhancements; partnerships, collaborations, agreements; expansions; and acquisitions

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis:

  • Product matrix, which gives a detailed comparison of the product portfolios of the five major companies

Company Information:

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
MD 4870
Published ON
Feb, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Transplant Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home